One of the fundamental reasons for the inconsistency of these lines of evidence-on the one hand, a strong genetic element suggested by the association with B lymphocyte alloantigens, and on the other, a weaker genetic contribution indicated by the family studies-may be the disease heterogeneity, which was perhaps not taken sufficiently into consideration in the initial investigations. Several observations in man clearly indicate that different genetic factors may be involved in different types of rheumatoid arthritis.'2 A strong association between HLA-DR4 and seropositive (rheumatoid factor; RF+) rheumatoid arthritis patients is established in white Europeans, whereas in contrast the frequency of DR4 in seronegative (RF-) patients is similar to that of the control. '3 These HLA results in man, though there is some lack of consistency, are supported by experimental studies in certain mammals, 14 and overall they indicate that seronegative and seropositive patients may be two different genetic subsections of the disease population, with different pathogenetic mechanisms bringing about phenotypically similar diseases.
Another autoantibody frequently encountered in patients with RA is associated with nuclear antigen. The extent of genetic control of antinuclear antibodies (ANA) is not clearly understood, but their association with 'autoimmune' disease suggests that they may play an integral part in the development of the disease. 5 Once again, depending on the presence or absence of ANA, two populations of patients with RA can be distinguished. The interaction of those gene(s) responsible for the production of the autoantibodies may influence the course and severity of the RA. 6 17 The aim of the present study, therefore, was to apply available genetic methods to inquire if the patients of different humoral status represent different populations of the same disease. Since the phenotypic expression of the disease will depend on the interactions within the total genotype of the patients the approach here followed was to investigate a large number of single gene markers in systems other than HLA in patient groups of different humoral status, and summarise these data in a single measure of genetic heterogeneity.
Patients and methods

PATIENT AND CONTROLS
A random collection of 225 adult patients fulfilling the criteria of the American Rheumatism Association for the classification of rheumatoid arthritis was included in this study. '8 All the patients were white and from the north east of England. They had been followed up in outpatient clinics for three to 30 years. Eighty per cent of the total patient population were over 50 years of age and 40% over 60 years. The control group of 104 individuals was matched proportionately for sex and region and was mainly drawn from the electoral register.
EXPERIMENTAL PROCEDURE
Five millilitres of blood was obtained from each patient and control by venepuncture,' into ethylenediaminetetra-acetate (EDTA) tubes. The samples were sent to the laboratory within four hours of collection. The plasma sample was separated and stored at -30°C for serum protein examination, and the red cells were analysed for blood groups. After washing the red cells with normal saline, lysates were prepared with equal amounts of water for the examination of red cell enzyme.
BLOOD GROUPS
The red cells were typed using the following antisera: A1, A2, B, A+B, M,N, S,s, C,c,CW, E,e,D, Fya, Fyb, P, K,k, Jka, Jkb, Lua, Lub, Lea ANA', and RF-ANA-.
The phenotype numbers and frequencies for each system (blood groups, red cell enzymes and serum proteins) in the total number of patients with RA, the subgroups, and the controls are listed in Table 2 . Tested by x2, no system shared any deviation of phenotype numbers from the expected. Compared with other surveys of healthy subjects the P blood groups showed slightly aberrant frequencies in the present controls, therefore interpretation of associations if any with this system requires caution. The gene frequencies of the various systems are given in Table 3 .
The frequencies of the A and B genes were lower in all the five subgroups than in the control group, but the differences were small and not statistically significant. The absence of B blood group from the seronegative group (RF-ANA-) is probably due to the small sample size. The raised Rh positive frequency observed in other studies26 could not be (Table 4) .
RED CELL ENZYMES
For the red cell enzyme polymorphisms there was a considerable range of gene frequency variation among patient groups, shown for example by the alleles GPT*2 (39-53%); PGM1*1+ (60-73%); AP*C (2-7%); EsD*2 (9-17%), and ADA*2 (4-10%). Overall there was no significant association found between RA and the genes of any enzyme system.
MULTIVARIATE ANALYSIS
Consideration allele by allele of the differences between patients with RA and controls, and among the various RA patient groups, is not very informative in the detection of genetic differences among them. It is by no means unusual that minor differences in a number of features which seem to Table 5 gives the R matrix obtained from the gene frequency data of blood groups, serum proteins, and red cell enzymes. Genetic distinction between the control and the rheumatoid population was shown by the consistently negative values of the control group compared with each of the other subsamples. The patients with both humoral factors present showed negative values against the RF+ANA-and RF-ANA-subgroups, suggesting the least affinity with these groups. Genetic distance was analysed only on the patient subgroups (RF+ANA-; RF+ANA+; RF-ANA-) and controls.
The genetic distances (d2) derived from the R matrix are given in Table 6 . The largest distance of 0-034 was found between the RF+ANA+ and RF-ANA-subgroups. Other large distances were found between RF-ANA-and controls, and RF-ANA-and RF+ANA-groups (0.026 and 0-025 respectively).
The d2 matrices were reduced to two dimensional plots by using the first two eigenvectors in a principal component analysis and a dendrogram based on the maximum linkage method (Figs 1 and 2 respectively). The isolated position in these plots of the RF-ANA-group is probably partly due to their small sample size, but the genetic distinction of the patients with both humoral factors is beyond doubt. 
Discussion
As an illustration of the usefulness of polymorphism for understanding genetic heterogeneity and disease aetiology this investigation of the association of genetic markers and rheumatoid arthritis is quite encouraging. It is appreciated that in multiple testing some apparently conventionally significant results may arise by chance, and this may be one interpretation of the findings in the MN, Lea, and Bf There is marked association with Bf in the total group of patients with RA and patients with the rheumatoid factor. Other immunogenetic studies suggest an association of HLA-DR4 or an unknown immune response gene in linkage disequilibrium with the D locus in seropositive (RF+) rheumatoid arthritis patients. The Bf gene is also located within the major histocompatibility region, and the association found with it could well suggest an association with an immune response gene through the phenomena of linkage disequilibrium. Futher analysis of extended haplotypes in families with RA may be helpful in predicting the defective immune response and precise genetic susceptibility to rheumatoid arthritis. It will also be useful to include other gene markers, like a, antitrypsin, which are thought to be associated with severe seropositive RA.
Another interesting association seems to be with the Lewis blood group, with a decrease of the Le(a) blood groups in patients with RA in whom both RF and ANA are present. How this Lewis association may be related to the aetiology of disease is not clear, but it seems to be worth further investigation since in another rheumatic disorder, primary Sjogren's syndrome, an association with the Lewis antigen has recently been shown. 29 Most studies of disease association have been conducted 
